Abstract:In vivo imaging of bacterial infection models enables noninvasive and temporal analysis of individuals, enhancing our understanding of infectious disease pathogenesis. Conventional in vivo imaging methods for bacterial infection models involve the insertion of the bacterial luciferase LuxCDABE into the bacterial genome, followed by imaging using an expensive ultrasensitive charge-coupled device (CCD) camera. However, issues such as limited light penetration into the body and lack of versatility have been encountered. We focused on near-infrared (NIR) light, which penetrates the body effectively, and attempted to establish an in vivo imaging method to evaluate the number of lung-colonizing bacteria during the course of bacterial pneumonia. This was achieved by employing a novel versatile system that combines plasmid-expressing firefly luciferase bacteria, NIR substrate, and an inexpensive, scientific complementary metal-oxide semiconductor (sCMOS) camera. The D-luciferin derivative "TokeOni," capable of emitting NIR bioluminescence, was utilized in a mouse lung infection model of Acinetobacter baumannii, an opportunistic pathogen that causes pneumonia and is a concern due to drug resistance. TokeOni exhibited the highest sensitivity in detecting bacteria colonizing the mouse lungs compared with other detection systems such as LuxCDABE, enabling the monitoring of changes in bacterial numbers over time and the assessment of antimicrobial agent efficacy. Additionally, it was effective in detecting A. baumannii clinical isolates and Klebsiella pneumoniae. The results of this study are expected to be used in the analysis of animal models of infectious diseases for assessing the efficacy of therapeutic agents and understanding disease pathogenesis. Importance: Conventional animal models of infectious diseases have traditionally relied upon average assessments involving numerous individuals, meaning they do not directly reflect changes in the pathology of an individual. Moreover, in recent years, ethical concerns have resulted in the demand to reduce the number of animals used in such models. Although in vivo imaging offers an effective approach for longitudinally evaluating the pathogenesis of infectious diseases in individual animals, a standardized method has not yet been established. To our knowledge, this study is the first to develop a highly versatile in vivo pulmonary bacterial quantification system utilizing near-infrared luminescence, plasmid-mediated expression of firefly luciferase in bacteria, and a scientific complementary metal-oxide semiconductor camera. Our research holds promise as a useful tool for assessing the efficacy of therapeutic drugs and pathogenesis of infectious diseases.

Imaging tuberculosis with endogenous β-lactamase reporter enzyme fluorescence in live mice

Imaging tuberculosis with endogenous beta-lactamase reporter enzyme fluorescence in live mice.

Real-Time Imaging Of Mycobacterium Tuberculosis, Using A Novel Near-Infrared Fluorescent Substrate

Whole-animal Imaging of Bacterial Infection Using Endoscopic Excitation of Β-Lactamase (Blac)-Specific Fluorogenic Probe

Intravital Excitation Increases Detection Sensitivity For Pulmonary Tuberculosis By Whole-Body Imaging With -Lactamase Reporter Enzyme Fluorescence

Rapid and specific labeling of single live Mycobacterium tuberculosis with a dual-targeting fluorogenic probe

In Vivo Optical Imaging of Bacterial Infection and Antibiotic Response in Intact Nude Mice

The Application of Anti-Esat-6 Monoclonal Antibody Fluorescent Probe in Ex Vivo Near-Infrared Fluorescence Imaging in Mice with Pulmonary Tuberculosis.

Highly Sensitive In Vivo Imaging of Bacterial Infections with a Hydrophilicity‐Switching, Self‐Immobilizing, Near‐Infrared Fluorogenic β‐Lactamase Probe Enriched within Bacteria

Near-infrared in vivo imaging system for dynamic visualization of lung-colonizing bacteria in mouse pneumonia

A Highly Selective Fluorescent Probe for Real-Time Imaging of Bacterial NAT2 and High-Throughput Screening of Natural Inhibitors for Tuberculosis Therapy

High-throughput fluorescent screening of β-lactamase inhibitors to improve antibiotic treatment strategies for tuberculosis

Monitoring Live Mycobacteria in Real-Time Using a Microfluidic Acoustic-Raman Platform

Imaging cytosolic translocation of Mycobacteria with two-photon fluorescence resonance energy transfer microscopy.

Optical Imaging of Bacterial Infection in Living Mice Using A Fluorescent Near-Infrared Molecular Probe

In Vivo Dynamic Monitoring of Bacterial Infection by NIR-II Fluorescence Imaging.

From Bench to Clinic: A Nitroreductase Rv3368c-Responsive Cyanine-Based Probe for the Specific Detection of Live Mycobacterium Tuberculosis.

In vivo Labeling and Intravital Imaging of Bacterial Infection using a Near‐infrared Fluorescent D‐Amino Acid Probe

Whole-Body Imaging of Bacteria Expressing Mkate 2 Fluorescence

A Fluorogenic Trehalose Probe for Tracking Phagocytosed Mycobacterium tuberculosis

A highly selective fluorescent probe for real-time imaging of bacterial NAT2 and high-throughput screening of natural inhibitors for tuberculosis therapy (vol 3, pg 145, 2019)